Skip to main content
Top
Published in: Arthritis Research & Therapy 2/2008

Open Access 01-04-2008 | Research article

Mild autonomic dysfunction in primary Sjögren's syndrome: a controlled study

Authors: Fin ZJ Cai, Sue Lester, Tim Lu, Helen Keen, Karyn Boundy, Susanna M Proudman, Anne Tonkin, Maureen Rischmueller

Published in: Arthritis Research & Therapy | Issue 2/2008

Login to get access

Abstract

Introduction

The aim of this study was to compare cardiovascular autonomic nervous system function in patients with primary Sjögren's syndrome (pSS) with that in control individuals, and to correlate the findings with autonomic symptoms and the presence of exocrine secretory dysfunction.

Methods

Twenty-seven female patients with pSS and 25 control individuals completed the COMPASS (Composite Autonomic Symptom Scale) self-reported autonomic symptom questionnaire. Beat-to-beat heart rate and blood pressure data in response to five standard cardiovascular reflex tests were digitally recorded using a noninvasive finger pressure cuff and heart rate variability was analyzed by Fourier spectral analysis. Analysis was performed by analysis of variance (ANOVA), multivariate ANOVA and repeated measures ANOVA, as indicated. Factor analysis was utilized to detect relationships between positive autonomic symptoms in pSS patients.

Results

Multiple, mild autonomic disturbances were observed in pSS patients relating to decreased heart rate variability, decreased blood pressure variability and increased heart rate, which were most evident in response to postural change. There was a strong trend toward an association between decreased heart rate variability and increased severity of the secretomotor, orthostatic, bladder, gastroparesis and constipation self-reported autonomic symptom cluster identified in pSS patients. This symptom cluster was also associated with fatigue and reduced unstimulated salivary flow, and therefore may be an important component of the clinical spectrum of this disease.

Conclusion

There was evidence of mild autonomic dysfunction in pSS as measured with both cardiovascular reflex testing and self-reported symptoms. Pathogenic autoantibodies targeting M3 muscarinic receptors remain a strong candidate for the underlying pathophysiology, but practical assays for the detection of this autoantibody remain elusive.
Appendix
Available only for authorised users
Literature
1.
go back to reference Griffin JW, Cornblath DR, Alexander E, Campbell J, Low PA, Bird S, Feldman EL: Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjogren's syndrome. Ann Neurol. 1990, 27: 304-315. 10.1002/ana.410270313.CrossRefPubMed Griffin JW, Cornblath DR, Alexander E, Campbell J, Low PA, Bird S, Feldman EL: Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjogren's syndrome. Ann Neurol. 1990, 27: 304-315. 10.1002/ana.410270313.CrossRefPubMed
2.
go back to reference Wang F, Jackson MW, Maughan V, Cavill D, Smith AJ, Waterman SA, Gordon TP: Passive transfer of Sjogren's syndrome IgG produces the pathophysiology of overactive bladder. Arthritis Rheum. 2004, 50: 3637-3645. 10.1002/art.20625.CrossRefPubMed Wang F, Jackson MW, Maughan V, Cavill D, Smith AJ, Waterman SA, Gordon TP: Passive transfer of Sjogren's syndrome IgG produces the pathophysiology of overactive bladder. Arthritis Rheum. 2004, 50: 3637-3645. 10.1002/art.20625.CrossRefPubMed
3.
go back to reference Waterman SA, Gordon TP, Rischmueller M: Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjogren's syndrome. Arthritis Rheum. 2000, 43: 1647-1654. 10.1002/1529-0131(200007)43:7<1647::AID-ANR31>3.0.CO;2-P.CrossRefPubMed Waterman SA, Gordon TP, Rischmueller M: Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjogren's syndrome. Arthritis Rheum. 2000, 43: 1647-1654. 10.1002/1529-0131(200007)43:7<1647::AID-ANR31>3.0.CO;2-P.CrossRefPubMed
4.
go back to reference Niemela RK, Pikkujamsa SM, Hakala M, Huikuri HV, Airaksinen KE: No signs of autonomic nervous system dysfunction in primary Sjorgen's syndrome evaluated by 24 hour heart rate variability. J Rheumatol. 2000, 27: 2605-2610.PubMed Niemela RK, Pikkujamsa SM, Hakala M, Huikuri HV, Airaksinen KE: No signs of autonomic nervous system dysfunction in primary Sjorgen's syndrome evaluated by 24 hour heart rate variability. J Rheumatol. 2000, 27: 2605-2610.PubMed
5.
go back to reference Niemela RK, Hakala M, Huikuri HV, Airaksinen KE: Comprehensive study of autonomic function in a population with primary Sjogren's syndrome. No evidence of autonomic involvement. J Rheumatol. 2003, 30: 74-79.PubMed Niemela RK, Hakala M, Huikuri HV, Airaksinen KE: Comprehensive study of autonomic function in a population with primary Sjogren's syndrome. No evidence of autonomic involvement. J Rheumatol. 2003, 30: 74-79.PubMed
6.
go back to reference Tumiati B, Perazzoli F, Negro A, Pantaleoni M, Regolisti G: Heart rate variability in patients with Sjogren's syndrome. Clin Rheumatol. 2000, 19: 477-480. 10.1007/PL00011180.CrossRefPubMed Tumiati B, Perazzoli F, Negro A, Pantaleoni M, Regolisti G: Heart rate variability in patients with Sjogren's syndrome. Clin Rheumatol. 2000, 19: 477-480. 10.1007/PL00011180.CrossRefPubMed
7.
go back to reference Barendregt PJ, van Den Meiracker AH, Markusse HM, Tulen JH, Boomsma F, van Der Heijde GL, Veld AJ: Parasympathetic failure does not contribute to ocular dryness in primary Sjogren's syndrome. Ann Rheum Dis. 1999, 58: 746-750.PubMedCentralCrossRefPubMed Barendregt PJ, van Den Meiracker AH, Markusse HM, Tulen JH, Boomsma F, van Der Heijde GL, Veld AJ: Parasympathetic failure does not contribute to ocular dryness in primary Sjogren's syndrome. Ann Rheum Dis. 1999, 58: 746-750.PubMedCentralCrossRefPubMed
8.
go back to reference Kovacs L, Paprika D, Takacs R, Kardos A, Varkonyi TT, Lengyel C, Kovacs A, Rudas L, Pokorny G: Cardiovascular autonomic dysfunction in primary Sjogren's syndrome. Rheumatology (Oxford). 2004, 43: 95-99. 10.1093/rheumatology/keg468.CrossRef Kovacs L, Paprika D, Takacs R, Kardos A, Varkonyi TT, Lengyel C, Kovacs A, Rudas L, Pokorny G: Cardiovascular autonomic dysfunction in primary Sjogren's syndrome. Rheumatology (Oxford). 2004, 43: 95-99. 10.1093/rheumatology/keg468.CrossRef
9.
go back to reference Mandl T, Bornmyr SV, Castenfors J, Jacobsson LT, Manthorpe R, Wollmer P: Sympathetic dysfunction in patients with primary Sjogren's syndrome. J Rheumatol. 2001, 28: 296-301.PubMed Mandl T, Bornmyr SV, Castenfors J, Jacobsson LT, Manthorpe R, Wollmer P: Sympathetic dysfunction in patients with primary Sjogren's syndrome. J Rheumatol. 2001, 28: 296-301.PubMed
10.
go back to reference Mandl T, Wollmer P, Manthorpe R, Jacobsson LT: Autonomic and orthostatic dysfunction in primary Sjogren's syndrome. J Rheumatol. 2007, 34: 1869-1874.PubMed Mandl T, Wollmer P, Manthorpe R, Jacobsson LT: Autonomic and orthostatic dysfunction in primary Sjogren's syndrome. J Rheumatol. 2007, 34: 1869-1874.PubMed
11.
go back to reference Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH, European Study Group on Classification Criteria for Sjögren's Syndrome: Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002, 61: 554-558. 10.1136/ard.61.6.554.PubMedCentralCrossRefPubMed Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH, European Study Group on Classification Criteria for Sjögren's Syndrome: Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002, 61: 554-558. 10.1136/ard.61.6.554.PubMedCentralCrossRefPubMed
12.
go back to reference Webster K, Cella D, Yost K: The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation. Health Qual Life Outcomes. 2003, 1: 79-10.1186/1477-7525-1-79.PubMedCentralCrossRefPubMed Webster K, Cella D, Yost K: The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation. Health Qual Life Outcomes. 2003, 1: 79-10.1186/1477-7525-1-79.PubMedCentralCrossRefPubMed
13.
go back to reference Suarez GA, Opfer-Gehrking TL, Offord KP, Atkinson EJ, O'Brien PC, Low PA: The Autonomic Symptom Profile: a new instrument to assess autonomic symptoms. Neurology. 1999, 52: 523-528.CrossRefPubMed Suarez GA, Opfer-Gehrking TL, Offord KP, Atkinson EJ, O'Brien PC, Low PA: The Autonomic Symptom Profile: a new instrument to assess autonomic symptoms. Neurology. 1999, 52: 523-528.CrossRefPubMed
14.
go back to reference Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P: International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003, 35: 1381-1395. 10.1249/01.MSS.0000078924.61453.FB.CrossRefPubMed Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P: International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003, 35: 1381-1395. 10.1249/01.MSS.0000078924.61453.FB.CrossRefPubMed
15.
go back to reference Penaz L: Photoelectric measurement of blood pressure, volume and flow in the finger. Digest of the 10th International Conference on Medicine and Biological Engineering. Dresden. Edited by: Albert R, Vogt WS, Helberg W. 1973, 104-(abstract) Penaz L: Photoelectric measurement of blood pressure, volume and flow in the finger. Digest of the 10th International Conference on Medicine and Biological Engineering. Dresden. Edited by: Albert R, Vogt WS, Helberg W. 1973, 104-(abstract)
16.
go back to reference Ewing DJ, Martyn CN, Young RJ, Clarke BF: The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care. 1985, 8: 491-498. 10.2337/diacare.8.5.491.CrossRefPubMed Ewing DJ, Martyn CN, Young RJ, Clarke BF: The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care. 1985, 8: 491-498. 10.2337/diacare.8.5.491.CrossRefPubMed
18.
go back to reference Task Force of the European Society of Cardiology the North American Society of Pacing Electrophysiology: Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation. 1996, 93: 1043-1065.CrossRef Task Force of the European Society of Cardiology the North American Society of Pacing Electrophysiology: Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation. 1996, 93: 1043-1065.CrossRef
19.
go back to reference Laude D, Elghozi JL, Girard A, Bellard E, Bouhaddi M, Castiglioni P, Cerutti C, Cividjian A, Di Rienzo M, Fortrat JO, Janssen B, Karemaker JM, Lefthériotis G, Parati G, Persson PB, Porta A, Quintin L, Regnard J, Rüdiger H, Stauss HM: Comparison of various techniques used to estimate spontaneous baroreflex sensitivity (the EuroBaVar study). Am J Physiol Regul Integr Comp Physiol. 2004, 286: R226-R231.CrossRefPubMed Laude D, Elghozi JL, Girard A, Bellard E, Bouhaddi M, Castiglioni P, Cerutti C, Cividjian A, Di Rienzo M, Fortrat JO, Janssen B, Karemaker JM, Lefthériotis G, Parati G, Persson PB, Porta A, Quintin L, Regnard J, Rüdiger H, Stauss HM: Comparison of various techniques used to estimate spontaneous baroreflex sensitivity (the EuroBaVar study). Am J Physiol Regul Integr Comp Physiol. 2004, 286: R226-R231.CrossRefPubMed
20.
go back to reference Ziegler D, Laux G, Dannehl K, Spuler M, Muhlen H, Mayer P, Gries FA: Assessment of cardiovascular autonomic function: age-related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses. Diabet Med. 1992, 9: 166-175.CrossRefPubMed Ziegler D, Laux G, Dannehl K, Spuler M, Muhlen H, Mayer P, Gries FA: Assessment of cardiovascular autonomic function: age-related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses. Diabet Med. 1992, 9: 166-175.CrossRefPubMed
21.
go back to reference Walker J, Gordon T, Lester S, Downie-Doyle S, McEvoy D, Pile K, Waterman S, Rischmueller M: Increased severity of lower urinary tract symptoms and daytime somnolence in primary Sjogren's syndrome. J Rheumatol. 2003, 30: 2406-2412.PubMed Walker J, Gordon T, Lester S, Downie-Doyle S, McEvoy D, Pile K, Waterman S, Rischmueller M: Increased severity of lower urinary tract symptoms and daytime somnolence in primary Sjogren's syndrome. J Rheumatol. 2003, 30: 2406-2412.PubMed
22.
go back to reference Pancera P, Sansone S, Presciuttini B, Montagna L, Ceru S, Lunardi C, Lechi A: Autonomic nervous system dysfunction in sclerodermic and primary Raynaud's phenomenon. Clin Sci (Lond). 1999, 96: 49-57. Pancera P, Sansone S, Presciuttini B, Montagna L, Ceru S, Lunardi C, Lechi A: Autonomic nervous system dysfunction in sclerodermic and primary Raynaud's phenomenon. Clin Sci (Lond). 1999, 96: 49-57.
23.
go back to reference Leppilahti M, Tammela TL, Huhtala H, Kiilholma P, Leppilahti K, Auvinen A: Interstitial cystitis-like urinary symptoms among patients with Sjogren's syndrome: a population-based study in Finland. Am J Med. 2003, 115: 62-65. 10.1016/S0002-9343(03)00257-2.CrossRefPubMed Leppilahti M, Tammela TL, Huhtala H, Kiilholma P, Leppilahti K, Auvinen A: Interstitial cystitis-like urinary symptoms among patients with Sjogren's syndrome: a population-based study in Finland. Am J Med. 2003, 115: 62-65. 10.1016/S0002-9343(03)00257-2.CrossRefPubMed
24.
go back to reference Kovacs L, Papos M, Takacs R, Roka R, Csenke Z, Kovacs A, Varkonyi T, Pajor L, Pavics L, Pokorny G: Autonomic nervous system dysfunction involving the gastrointestinal and the urinary tracts in primary Sjogren's syndrome. Clin Exp Rheumatol. 2003, 21: 697-703.PubMed Kovacs L, Papos M, Takacs R, Roka R, Csenke Z, Kovacs A, Varkonyi T, Pajor L, Pavics L, Pokorny G: Autonomic nervous system dysfunction involving the gastrointestinal and the urinary tracts in primary Sjogren's syndrome. Clin Exp Rheumatol. 2003, 21: 697-703.PubMed
25.
go back to reference Andonopoulos AP, Christodoulou J, Ballas C, Bounas A, Alexopoulos D: Autonomic cardiovascular neuropathy in Sjogren's syndrome. A controlled study. J Rheumatol. 1998, 25: 2385-2388.PubMed Andonopoulos AP, Christodoulou J, Ballas C, Bounas A, Alexopoulos D: Autonomic cardiovascular neuropathy in Sjogren's syndrome. A controlled study. J Rheumatol. 1998, 25: 2385-2388.PubMed
26.
go back to reference Barendregt PJ, Tulen JH, van den Meiracker AH, Markusse HM: Spectral analysis of heart rate and blood pressure variability in primary Sjogren's syndrome. Ann Rheum Dis. 2002, 61: 232-236. 10.1136/ard.61.3.232.PubMedCentralCrossRefPubMed Barendregt PJ, Tulen JH, van den Meiracker AH, Markusse HM: Spectral analysis of heart rate and blood pressure variability in primary Sjogren's syndrome. Ann Rheum Dis. 2002, 61: 232-236. 10.1136/ard.61.3.232.PubMedCentralCrossRefPubMed
27.
go back to reference Mandl T, Jacobsson L, Lilja B, Sundkvist G, Manthorpe R: Disturbances of autonomic nervous function in primary Sjogren's syndrome. Scand J Rheumatol. 1997, 26: 401-406.CrossRefPubMed Mandl T, Jacobsson L, Lilja B, Sundkvist G, Manthorpe R: Disturbances of autonomic nervous function in primary Sjogren's syndrome. Scand J Rheumatol. 1997, 26: 401-406.CrossRefPubMed
28.
go back to reference Mori K, Iijima M, Koike H, Hattori N, Tanaka F, Watanabe H, Katsuno M, Fujita A, Aiba I, Ogata A, Saito T, Asakura K, Yoshida M, Hirayama M, Sobue G: The wide spectrum of clinical manifestations in Sjogren's syndrome-associated neuropathy. Brain. 2005, 128: 2518-2534. 10.1093/brain/awh605.CrossRefPubMed Mori K, Iijima M, Koike H, Hattori N, Tanaka F, Watanabe H, Katsuno M, Fujita A, Aiba I, Ogata A, Saito T, Asakura K, Yoshida M, Hirayama M, Sobue G: The wide spectrum of clinical manifestations in Sjogren's syndrome-associated neuropathy. Brain. 2005, 128: 2518-2534. 10.1093/brain/awh605.CrossRefPubMed
29.
go back to reference Elenkov IJ, Kovacs K, Duda E, Stark E, Vizi ES: Presynaptic inhibitory effect of TNF-alpha on the release of noradrenaline in isolated median eminence. J Neuroimmunol. 1992, 41: 117-120. 10.1016/0165-5728(92)90203-W.CrossRefPubMed Elenkov IJ, Kovacs K, Duda E, Stark E, Vizi ES: Presynaptic inhibitory effect of TNF-alpha on the release of noradrenaline in isolated median eminence. J Neuroimmunol. 1992, 41: 117-120. 10.1016/0165-5728(92)90203-W.CrossRefPubMed
30.
go back to reference Straub RH, Baerwald CG, Wahle M, Janig W: Autonomic dysfunction in rheumatic diseases. Rheum Dis Clin North Am. 2005, 31: 61-75. 10.1016/j.rdc.2004.09.002. viii.CrossRefPubMed Straub RH, Baerwald CG, Wahle M, Janig W: Autonomic dysfunction in rheumatic diseases. Rheum Dis Clin North Am. 2005, 31: 61-75. 10.1016/j.rdc.2004.09.002. viii.CrossRefPubMed
31.
go back to reference Bacman S, Perez Leiros C, Sterin-Borda L, Hubscher O, Arana R, Borda E: Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjogren's syndrome. Invest Ophthalmol Vis Sci. 1998, 39: 151-156.PubMed Bacman S, Perez Leiros C, Sterin-Borda L, Hubscher O, Arana R, Borda E: Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjogren's syndrome. Invest Ophthalmol Vis Sci. 1998, 39: 151-156.PubMed
32.
go back to reference Dawson LJ, Stanbury J, Venn N, Hasdimir B, Rogers SN, Smith PM: Antimuscarinic antibodies in primary Sjogren's syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells. Arthritis Rheum. 2006, 54: 1165-1173. 10.1002/art.21764.CrossRefPubMed Dawson LJ, Stanbury J, Venn N, Hasdimir B, Rogers SN, Smith PM: Antimuscarinic antibodies in primary Sjogren's syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells. Arthritis Rheum. 2006, 54: 1165-1173. 10.1002/art.21764.CrossRefPubMed
33.
go back to reference Goldblatt F, Gordon TP, Waterman SA: Antibody-mediated gastrointestinal dysmotility in scleroderma. Gastroenterology. 2002, 123: 1144-1150. 10.1053/gast.2002.36057.CrossRefPubMed Goldblatt F, Gordon TP, Waterman SA: Antibody-mediated gastrointestinal dysmotility in scleroderma. Gastroenterology. 2002, 123: 1144-1150. 10.1053/gast.2002.36057.CrossRefPubMed
34.
go back to reference Smith AJ, Jackson MW, Wang F, Cavill D, Rischmueller M, Gordon TP: Neutralization of muscarinic receptor autoantibodies by intravenous immunoglobulin in Sjogren syndrome. Hum Immunol. 2005, 66: 411-416. 10.1016/j.humimm.2005.01.020.CrossRefPubMed Smith AJ, Jackson MW, Wang F, Cavill D, Rischmueller M, Gordon TP: Neutralization of muscarinic receptor autoantibodies by intravenous immunoglobulin in Sjogren syndrome. Hum Immunol. 2005, 66: 411-416. 10.1016/j.humimm.2005.01.020.CrossRefPubMed
35.
go back to reference Wang H, Lu Y, Wang Z: Function of cardiac M3 receptors. Auton Autacoid Pharmacol. 2007, 27: 1-11. 10.1111/j.1474-8673.2006.00381.x.CrossRefPubMed Wang H, Lu Y, Wang Z: Function of cardiac M3 receptors. Auton Autacoid Pharmacol. 2007, 27: 1-11. 10.1111/j.1474-8673.2006.00381.x.CrossRefPubMed
36.
go back to reference Martinmaki K, Rusko H, Kooistra L, Kettunen J, Saalasti S: Intraindividual validation of heart rate variability indexes to measure vagal effects on hearts. Am J Physiol Heart Circ Physiol. 2006, 290: H640-H647. 10.1152/ajpheart.00054.2005.CrossRefPubMed Martinmaki K, Rusko H, Kooistra L, Kettunen J, Saalasti S: Intraindividual validation of heart rate variability indexes to measure vagal effects on hearts. Am J Physiol Heart Circ Physiol. 2006, 290: H640-H647. 10.1152/ajpheart.00054.2005.CrossRefPubMed
37.
go back to reference Khurana S, Chacon I, Xie G, Yamada M, Wess J, Raufman JP, Kennedy RH: Vasodilatory effects of cholinergic agonists are greatly diminished in aorta from M3R-/- mice. Eur J Pharmacol. 2004, 493: 127-132. 10.1016/j.ejphar.2004.04.012.CrossRefPubMed Khurana S, Chacon I, Xie G, Yamada M, Wess J, Raufman JP, Kennedy RH: Vasodilatory effects of cholinergic agonists are greatly diminished in aorta from M3R-/- mice. Eur J Pharmacol. 2004, 493: 127-132. 10.1016/j.ejphar.2004.04.012.CrossRefPubMed
38.
go back to reference Kovacs L, Torok T, Bari F, Keri Z, Kovacs A, Makula E, Pokorny G: Impaired microvascular response to cholinergic stimuli in primary Sjogren's syndrome. Ann Rheum Dis. 2000, 59: 48-53. 10.1136/ard.59.1.48.PubMedCentralCrossRefPubMed Kovacs L, Torok T, Bari F, Keri Z, Kovacs A, Makula E, Pokorny G: Impaired microvascular response to cholinergic stimuli in primary Sjogren's syndrome. Ann Rheum Dis. 2000, 59: 48-53. 10.1136/ard.59.1.48.PubMedCentralCrossRefPubMed
Metadata
Title
Mild autonomic dysfunction in primary Sjögren's syndrome: a controlled study
Authors
Fin ZJ Cai
Sue Lester
Tim Lu
Helen Keen
Karyn Boundy
Susanna M Proudman
Anne Tonkin
Maureen Rischmueller
Publication date
01-04-2008
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 2/2008
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar2385

Other articles of this Issue 2/2008

Arthritis Research & Therapy 2/2008 Go to the issue